SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 12b-25
NOTIFICATION OF LATE FILING
 
OMB APPROVAL
 
OMB Number:          3235-0058
 
Expires:           August 31, 2015
 
Estimated average burden
 
hours per response            2.50
   
 
SEC File Number
 
0-23336
   
 
CUSIP Number
 
042682 20 3
 
(Check one) o Form 10-K  o Form 20-F  o Form 11-K  T Form 10-Q  o Form 10-D  o Form N-SAR  o Form N-CSR
 
For Period Ended:
June 30, 2015
 
o Transition Report on Form 10-K
o Transition Report on Form 20-F
o Transition Report on Form 11-K
o Transition Report on Form 10-Q
o Transition Report on Form N-SAR
For the transition period ended:                                                                                                                    
 
 
 
 Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein
 
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 
 
 
PART I – REGISTRANT INFORMATION
 
Arotech Corporation
Full Name of Registrant
 
 
Former Name if Applicable
 
1229 Oak Valley Drive
Address of Principal Executive Office (Street and Number)
 
Ann Arbor, Michigan 48108
City, State and Zip Code
 
 
SEC 1344 (04-09)
 

Potential persons who are to respond to the collection of
information contained in this form are not required to respond
unless the form displays a currently valid OMB control number.
 
 
 
 
 
PART II – RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b) the following should be completed. (Check box if appropriate.)
 
 
(a)
The response described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
T
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     
 
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III – NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR or N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
(Attach extra Sheets if Needed)
 
We are still attempting to obtain certain documentation needed to complete the review of our financial statements and have been unable to do so by the required filing date of August 10, 2015 without the expenditure by us of unreasonable effort and expense.
 
We anticipate filing our Quarterly Report on Form 10-Q for the year ended June 30, 2015 within the regulatory five-day extension period.

PART IV – OTHER INFORMATION

(1)           Name and telephone number of person to contact in regard to this notification.

Yaakov Har-Oz
  
334
  
559-3304
(Name)
  
(Area Code)
  
(Telephone Number)

 (2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the Registrant was required to file such report(s) been filed? If answer is no, identify reports(s).            T   Yes       o   No
 
 
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statement to be included in the subject report or portion thereof?                                   o   Yes       T   No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
 
 
 


Arotech Corporation
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:
August 10, 2015
  
By:
    /s/   Yaakov Har-Oz
       
Name: Yaakov Har-Oz
       
Title:   Senior Vice President and General Counsel

 
 
Arotech (NASDAQ:ARTX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Arotech Charts.
Arotech (NASDAQ:ARTX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Arotech Charts.